FLI1 and breast carcinoma: We constructed a lentiviral vector containing the catalytically inactive CRISPR Cas9 (dCas9) and two FLI1 promoter gRNAs (Fig. 1d and Additional file 1: Figure S2) and transfected it into MDA-MB231 breast cancer cells.